Skip to content

Screener

Eligibility screening

Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Le…

Sponsored by AbbVieStudy detailsClinicalTrials.gov

13 US sites in AZ, CO, IN, MN +6

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.